We are live on ! Find out more
MDXG icon

MiMedx Group

186 hedge funds and large institutions have $473M invested in MiMedx Group in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 74 increasing their positions, 51 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 51

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less capital invested

Capital invested by funds: $491M → $473M (-$17.6M)

13% less funds holding

Funds holding: 213186 (-27)

55% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 47

77% less call options, than puts

Call options by funds: $18.2M | Put options by funds: $80.5M

Holders
186
Holders Change
-27
Holders Change %
-12.68%
% of All Funds
4.25%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
74
Reduced
51
Closed
47
Calls
$18.2M
Puts
$80.5M
Net Calls
-$62.2M
Net Calls Change
+$2.59M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$85.6M -$3.44M -762,073 -5%
State Street
2
State Street
Massachusetts
$57.5M +$2.79M +617,725 +7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$53.2M +$3.91M +864,031 +11%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$43.9M +$583K +129,014 +2%
Invesco
5
Invesco
Georgia
$11.7M +$3.24M +717,756 +61%
LCM
6
Lakewood Capital Management
New York
$11.4M +$4.52M +1,000,000 +117%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$11.3M +$607K +134,347 +8%
Norges Bank
8
Norges Bank
Norway
$9.28M
CIBC Private Wealth Group
9
CIBC Private Wealth Group
Georgia
$9.18M
TA
10
Tiedemann Advisors
New York
$8.98M -$1.13K -250 -0%
Arrowstreet Capital
11
Arrowstreet Capital
Massachusetts
$8.52M -$1.32M -293,160 -18%
Northern Trust
12
Northern Trust
Illinois
$8.48M -$20.1K -4,447 -0.3%
Wells Fargo
13
Wells Fargo
California
$6.85M +$1.58M +349,477 +46%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$6.58M +$228K +50,504 +5%
Principal Financial Group
15
Principal Financial Group
Iowa
$5.22M +$149K +32,896 +4%
Nordea Investment Management
16
Nordea Investment Management
Sweden
$4.89M +$1.84M +406,537 +106%
Group One Trading
17
Group One Trading
Illinois
$4.71M +$2.37M +524,984 +221%
Brown Advisory
18
Brown Advisory
Maryland
$4.39M +$210K +46,505 +7%
DGI
19
Disciplined Growth Investors
Minnesota
$4.37M -$26.5K -5,864 -0.8%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$4.29M +$784K +173,454 +33%
CCM
21
Cloverdale Capital Management
Texas
$4.17M +$3.05M +674,268 New
Deutsche Bank
22
Deutsche Bank
Germany
$4.15M +$1M +222,294 +50%
Charles Schwab
23
Charles Schwab
California
$3.88M -$151K -33,441 -5%
TIM
24
Thompson Investment Management
Wisconsin
$3.58M -$39.7K -8,780 -1%
Goldman Sachs
25
Goldman Sachs
New York
$3.58M +$428K +94,670 +20%

MDXG Hedge Fund Activity: Q3 2018 in Review

186 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q3 2018, worth a combined $473M — down 3.6% from $491M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of MDXG and 21 opened new positions — a net loss of 26 holders — while 51 trimmed existing stakes and 74 added.

The largest buyer was Lakewood Capital Management, adding an estimated $4.52M. The largest seller was Credit Suisse, cutting an estimated $6.01M.

  • 186 institutional investors held MiMedx Group (MDXG) as of Q3 2018, down from 213 in Q2 2018.
  • Funds reported $473M of MiMedx Group stock for Q3 2018, down 3.6% quarter-over-quarter.
  • 21 funds opened new MiMedx Group positions in Q3 2018 and 47 closed out, a net change of -26 holders.
  • The largest MiMedx Group buyer in Q3 2018 was Lakewood Capital Management, an estimated $4.52M added.
  • The largest MiMedx Group seller in Q3 2018 was Credit Suisse, an estimated $6.01M sold.

Based on aggregated 13F filings for Q3 2018.